Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti-D

Transfusion

Volumn 47, Issue 2, 2007, Pages 306-315

  Nielsen, Leif Kofoed ^a   Green, Trine Hefsgaard ^b   Norderhaug, Lars ^b   Sandlie, Inger ^b   Dziegiel, Morten Hanefeld ^b  

^a University of Copenhagen   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; RHESUS D ANTIBODY;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL CULTURE; CHEMOLUMINESCENCE; CHO CELL; CONTROLLED STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROPHYLAXIS; RESPIRATORY BURST;

ANIMALS; ANTIBODY SPECIFICITY; CHO CELLS; CRICETINAE; CRICETULUS; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT PROTEINS; RESPIRATORY BURST; RH-HR BLOOD-GROUP SYSTEM; TRANSFECTION;

EID: 33846426090     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01107.x     Document Type: Article

References (44)

1. Kumpel BM. Monoclonal anti-D development programme. Transplant Immunol 2002;10:199-204.
2. Klein P, Beliard R, Glacet A, et al. Human recombinant anti-Rh(D) monoclonal antibodies: improvement of biological properties by in vitro class-switch. Hum Antibodies 1997;8:17-25.
3. Paterson T, Innes J, McMillan L, et al. Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus(D) monoclonal antibodies. Immunotechnology 1998;4:37-47.
4. Miescher S, Zahn-Zabal M, De Jesus M, et al. CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. Br J Haematol 2000;111:157-66.
5. Miescher S, Spycher MO, Amstutz H, et al. A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the FcgammaRIIA and FcgammaIIIA genes. Blood 2004;103:4028-35.
6. Kumpel BM, Beliard R, Brossard Y, et al. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report. Transfus Clin Biol 2002;9:45-53.
7. Armour KL, Clark MR, Hadley AG, et al. Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities. Eur J Immunol 1999;29:2613-24.
8. Urbaniak SJ. The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol 1998;105(Suppl 18):11-8.
9. Shen L, Fanger MW. Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes. Cell Immunol 1981;59:75-81.
10. Stewart WW, Kerr MA. The measurement of respiratory burst induced in polymorphonuclear neutrophils by IgA and IgG anti-gliadin antibodies isolated from coeliac serum. Immunology 1991;73:491-7.
11. Shen L, Collins J. Monocyte superoxide secretion triggered by human IgA. Immunology 1989;68:491-6.
12. Kumpel BM. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). Immunol Lett 2002;82:67-73.
13. Dziegiel M, Nielsen LK, Andersen PS, et al. Phage display used for gene cloning of human recombinant antibody against the erythrocyte surface antigen, rhesus D. J Immunol Methods 1995;182:7-19.
14. Norderhaug L, Olafsen T, Michaelsen TE, et al. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods 1997;204:77-87.
15. Hougs L, Svejgaard A, Barington T. The first constantdomain (CH1) exon of human IGHG2 is polymorphic and in strong linkage disequilibrium with the CH2 exon polymorphism encoding the G2m (n+) allotype in Caucasians. Immunogenetics 2001;52:242-8.
16. Brekke OH, Michaelsen TE, Aase A, et al. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis. Eur J Immunol 1994;24:2542-7.
17. Sorensen V, Rasmussen IB, Norderhaug L, et al. Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG. J Immunol 1996;156:2858-65.
18. Nielsen LK, Norderhaug L, Sandlie I, et al. In vitro functional test of two subclasses of an anti-RhD antibody produced by transient expression in COS cells. APMIS 2006;114:345-51.
19. Boel E, Verlaan S, Poppelier MJ, et al. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments. J Immunol Methods 2000;239:153-66.
20. Dziegiel M, Borre MB, Jepsen S, et al. Recombinant Plasmodium falciparum glutamate rich protein: purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1991;44:306-13.
21. Bouquin T, Thomsen M, Nielsen LK, et al. Human antirhesus D IgG1 antibody produced in transgenic plants. Transgenic Res 2002;11:115-22.
22. Ducrot T, Beliard R, Glacet A, et al. Use of the DAF assay to assess the functional properties of polyclonal and monoclonal RhD antibodies. Vox Sang 1996;71:30-6.
23. Armstrong-Fisher SS, Carter MC, Downing I, et al. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function. Transfusion 1999;39:1005-12.
24. Lundquist R, Nielsen LK, Jafarshad A, et al. Human recombinant antibodies against plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties. Infect Immun 2006;74:3222-31.
25. Mattila PS, Seppala IJ, Eklund J, et al. Quantitation of immunoglobulin classes and subclasses in anti-Rh(D) antibodies. Vox Sang 1985;48:350-6.
26. Shaw DR, Conley ME, Knox FJ, et al. Direct quantitation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1(D) antibodies. Transfusion 1988;28:127-31.
27. Armstrong-Fisher SS, Sweeney GM, Greiss MA, et al. Functional assessment of therapeutic anti-D immunoglobulin using Fc-mediated assays. Transfus Med 1995;5:21-9.
28. Kumpel BM, van De Winkel JG, Westerdaal NA, et al. Antigen topography is critical for interaction of IgG2 antired-cell antibodies with Fc gamma receptors. Br J Haematol 1996;94:175-83.
29. Sokol RJ, Booker DJ, Stamps R, et al. IgA red cell autoantibodies and autoimmune hemolysis. Transfusion 1997;37:175-81.
30. Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol 2006;208:270-82.
31. Hadley AG, Kumpel BM, Merry AH. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh (D) antibodies. Clin Lab Haematol 1988;10:377-84.
32. Strachan AJ, Williams B, Mohabir L, et al. Human Rh monoclonal antibodies: assessment of functional activity by chemiluminescence and RhD antibody quantitation. Transfus Clin Biol 1996;3:483-7.
33. Kumpel BM, Hadley AG. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines. Mol Immunol 1990;27:247-56.
34. Hadley AG, Kumpel BM. Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells. Immunology 1989;67:550-2.
35. Wiener E, Jolliffe VM, Scott HC, et al. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Immunology 1988;65:159-63.
36. Kumpel BM. Coordinator's report. An assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories. Transfus Clin Biol 1996;3:439-52.
37. Kumpel BM. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D. Vox Sang 1997;72:45-51.
38. Siberil S, de Romeuf C, Bihoreau N, et al. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory FcgammaR functions. Clin Immunol 2006;118:170-9.
39. Munn LR, Chaplin H Jr. Rosette formation by sensitized human red cells: effects of source of peripheral leukocyte monolayers. Vox Sang 1977;33:129-42.
40. Douglas R, Rowthorne NV, Schneider JV. Some quantitative aspects of the human monocyte erythrophagocytosis and rosette assays. Transfusion 1985;25:535-9.
41. Hadley AG, Kumpel BM, Leader K, et al. An in-vitro assessment of the functional activity of monoclonal anti-D. Clin Lab Haematol 1989;11:47-54.
42. Garner SF, Thomson AR, Lubenko A, et al. Monocyte isolation by flow cytometer-monitored centrifugal elutriation: a preparative tool for antibody-dependent cell-mediated cytotoxicity (ADCC) assays. Br J Biomed Sci 1994;51:35-43.
43. Hadley AG, Poole GD, Amphlett NW, et al. The use of interferon-gamma- treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance. Clin Lab Haematol 1992;14:315-26.
44. Engelfriet CP, Ouwehand WH. ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies. Baillieres Clin Haematol 1990;3:321-37.